Myron Z. Holubiak, President and CEO at Citius Pharmaceuticals, Inc. (CTXR), bought 1,568,628 shares at $1.28 ($2.0M) on 2018-08-13, disclosed to the SEC on 2018-08-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.28 | 784,314 | $1.0M | 50.0% |
| 2 | $1.28 | 784,314 | $1.0M | 50.0% |
| Total | $1.28 avg | 1,568,628 | $2.0M | 100% |
| Filing → |
| CTXR | BUY | 2018-03-29 | $9K | — | Filing → |
| BIOS | SELL | 2014-06-18 | $40K | — | Filing → |
| BIOS | SELL | 2013-07-23 | $510K | — | Filing → |